BIONORICA

BRONCHIPRET TP 20 FILM-COATED TABLETS

You're reading an Auto-translation.

Composition. The active substances are 60 mg extract (as dry extract) from Primula veris L./Primula elatior (L.) Hill, radix (cowslip root) (6 - 7 : 1). Extraction solvent: ethanol 47.4% (V/V) 160 mg extract (as dry extract) from Thymus vulgaris L./Thymus zygis L., herba (thyme herb) (6 - 10 : 1). Extraction solvent: ethanol 70% (V/V). The other components are: microcrystalline cellulose; lactose monohydrate; glucose, liquid, spray-dried; colloidal anhydrous silicon dioxide; polyacrylate dispersion 30%; crospovidone; hypromellose; talc; povidone K 25; magnesium stearate; titanium dioxide (E171); propylene glycol; mint flavor; acacia gum; maltodextrin; lactose; copper-chlorophyllin E 141; glucose syrup; sodium saccharin; simethicone; dimethicone; riboflavin (E101).

Therapeutic indications.

Bronchipret TP is a herbal medicine used in cases of productive cough to facilitate the expectoration of viscous mucus.

If you do not feel better or feel worse after 1 week, you should consult a doctor.

Dosage and administration.

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Talk to your doctor or pharmacist if you are not sure.

The recommended dose is:

Adults: 1 film-coated tablet 3 times a day (maximum 3 film-coated tablets per day). Take Bronchipret TP tablets without chewing, before meals, with a sufficient amount of liquid (preferably, with a glass of water).

If symptoms persist during the use of the medicine for more than 1 week, you should consult a doctor or another healthcare professional.

There is insufficient data regarding the recommended dose in patients with impaired kidney/liver function.

Precautions.

Talk to your doctor or pharmacist

- if you have difficulty breathing, fever, or purulent sputum

- if you have gastritis or gastric ulcer

- if symptoms worsen during the use of the medicine

Children and adolescents

Use in children and adolescents under 18 years of age has not yet been established due to a lack of adequate efficacy data.

Special warnings.

Pregnancy and breastfeeding

Safety during pregnancy has not been established. In the absence of sufficient data, use during pregnancy is not recommended. It is not known whether the active substances in Bronchipret TP or its metabolites are excreted in human milk. Therefore, Bronchipret TP should not be used during breastfeeding.

Driving and operating machinery

Bronchipret TP has no or negligible influence on the ability to drive or operate machinery.

Packaging. Box with a type III, colorless glass bottle, containing 100 ml (130 g) oral solution, equipped with a child-resistant closure system, consisting of a PP cap, with an inner layer of PE/Al/PE and a PP measuring cup, with graduations for measuring volumes 2.5 ml; 5.0 ml; 7.5 ml; 10 ml; 12.5 ml; 15 ml.

Page updated on: 09.06.2021